Abraham K, Krowke R, Neubert D
Institut für Toxikologie und Embryopharmakologie, Freie Universität Berlin.
Arch Toxicol. 1988;62(5):359-68. doi: 10.1007/BF00293624.
Concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat liver and adipose tissue, and hepatic ethoxyresorufin O-deethylase (EROD) activity were studied subsequent to a single subcutaneous injection of TCDD. Two types of experiments were performed to study: (a) time-dependent changes following a single injection of 300 ng TCDD/kg body wt (points 1-4), and (b) dose-dependent changes measurable after 7 days following a single injection (points 5-7). 1. Absorption of TCDD following a single subcutaneous injection was about 90% after 3 days and 98% after 5 days. 2. Following a single dose of 300 ng TCDD/kg body wt peak concentrations were: liver (after 3 days): 4.7 +/- 0.9 ng/g wet wt, and adipose tissue (after 7 days): 0.82 +/- 0.07 ng/g wet wt. 3. T1/2 of TCDD in liver was 13.6 days over the total experimental period (from day 10 to 91 of the study), apparently with an initial faster phase: 11.5 days (from day 10 to 49), and a slower period at the end of the experiment: 16.9 days (from day 49 to 91); in adipose tissue the t1/2 was 24.5 days (from day 14 to 91 of the study). 4. Maximum induction of EROD in the liver was observed (14-fold at 300 ng TCDD/kg body wt) 3-7 days following the injection; the activity was decreased to about one third of the maximum 3 weeks after the injection; increase in total cytochrome P-450 at this dose was only about 1.4-fold at the induction maximum. 5. The ratio of the TCDD concentrations in liver and adipose tissue increased considerably between doses of 3 ng TCDD/kg body wt (ratio: about 0.74) and 3000 ng TCDD/kg body wt (ratio: about 7.7). 6. The extent of EROD induction in the liver increased dose dependently. A significant effect was first observed with a dose of 3 ng TCDD/kg body wt (activity about +32% above control activity). The corresponding tissue concentration was about 10 pg TCDD/g liver wet wt. 7. An almost perfect linear relationship exists (when using a double-log plot) between the hepatic TCDD concentration and the EROD activity for tissue concentrations ranging from 40 to 30,000 pg TCDD/g wet wt.
在对大鼠进行单次皮下注射2,3,7,8 - 四氯二苯并 - p - 二恶英(TCDD)后,研究了其肝脏和脂肪组织中TCDD的浓度以及肝脏乙氧基异吩恶唑酮 - O - 脱乙基酶(EROD)的活性。进行了两种类型的实验来研究:(a)单次注射300 ng TCDD/kg体重后的时间依赖性变化(第1 - 4点),以及(b)单次注射7天后可测量的剂量依赖性变化(第5 - 7点)。1. 单次皮下注射后,TCDD的吸收率在3天后约为90%,5天后为98%。2. 单次给予300 ng TCDD/kg体重后,峰值浓度为:肝脏(3天后):4.7±0.9 ng/g湿重,脂肪组织(7天后):0.82±0.07 ng/g湿重。3. 在整个实验期间(从研究的第10天到第91天),肝脏中TCDD的半衰期为13.6天,显然最初阶段较快:11.5天(从第10天到第49天),实验结束时较慢:16.9天(从第49天到第91天);在脂肪组织中,半衰期为24.5天(从研究的第14天到第91天)。4. 注射后3 - 7天观察到肝脏中EROD的最大诱导(在300 ng TCDD/kg体重时为14倍);注射3周后活性降至最大值的约三分之一;在此剂量下,总细胞色素P - 450在诱导最大值时仅增加约1.4倍。5. 在3 ng TCDD/kg体重(比值:约0.74)和3000 ng TCDD/kg体重(比值:约7.7)的剂量之间,肝脏和脂肪组织中TCDD浓度的比值显著增加。6. 肝脏中EROD诱导的程度呈剂量依赖性增加。首次在3 ng TCDD/kg体重的剂量下观察到显著影响(活性比对照活性高约32%)。相应的组织浓度约为10 pg TCDD/g肝脏湿重。7. 对于组织浓度范围为40至30,000 pg TCDD/g湿重的情况,肝脏TCDD浓度与EROD活性之间存在几乎完美的线性关系(使用双对数图时)。